SOSV

At Kfobix, our mission is to revolutionize the green energy landscape, making it more efficient and sustainable. In a world increasingly impacted by climate change, our mission is critical: to facilitate a seamless transition to renewable energy sources. We specialize in creating cutting-edge superhydrophobic coatings that prevent ice formation on electrical transmission lines and wind turbines. This not only enhances the reliability of green energy infrastructure but also ensures uninterrupted energy production and transmission. Our innovation extends to the solar energy sector, where we are pioneering anti-dirt coatings. These coatings are designed to maintain the cleanliness of solar panels, thereby maximizing their efficiency and output. Our products represent a leap forward in nanotechnology, offering practical solutions to some of the most pressing challenges in the renewable energy sector. At Kfobix, we are driven by the belief that the future of energy can be cleaner, more reliable, and utterly sustainable. Our journey is marked by relentless research and development, pushing the boundaries of what is possible. By joining forces with us, you become part of a movement that is not just preparing for a sustainable future but actively building it, today. Let’s empower the world together with cleaner, more efficient energy solutions.

NanoPlume is a biomaterial company focused on the large-scale production of innovative biomaterials, particularly Bio-Aerogel.

Minutia is focused on developing innovative solutions for Type 1 Diabetes through stem cell-derived transplants that incorporate nanosensors. The company specializes in creating subcutaneous insulin-producing cell transplants that are immune-evasive and capable of real-time monitoring via proprietary cell-based sensors. This approach aims to address common challenges associated with transplants and seeks to provide a functional cure for diabetes. By advancing both transplantation techniques and monitoring capabilities, Minutia aspires to transform the clinical landscape of diabetes management and cell replacement therapies.

BioMetallum is a biomining company that designs and develops solutions for extracting lithium and other metals.

Navion Energy specializes in portable energy storage solutions that integrate sodium-ion technology for sustainability and efficiency.

Mesa Quantum is an electronics manufacturing company focused on developing advanced quantum technology solutions. It specializes in photonic quantum computing hardware, offering integrated chip-scale systems that encode and manipulate quantum information. This innovative approach aims to enhance computing power by providing significant advantages in scalability and stability over traditional methods. By leveraging its technology, Mesa Quantum enables customers to tackle complex problems that are difficult or impossible to solve with classical computing systems.

Level Zero Health focuses on advanced biosensor technology to collect new types of data by combining biochemistry and nanotechnology.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

BioAesthetics LLC, founded in 2015 as a spin-out from Tulane University, is focused on developing innovative reconstruction options for breast cancer patients following mastectomies. The company specializes in a tissue-engineered nipple-areolar complex (NAC) that serves as an acellular graft to be used by plastic and reconstructive surgeons during the breast reconstruction phase. This product allows the patient's own cells to integrate with the graft, facilitating the regeneration of a natural nipple and areola. Currently in the pre-clinical phase, this patent-pending technology aims to provide a more effective and aesthetically pleasing solution for patients who have experienced incomplete or removed NACs due to illness, surgery, or congenital conditions. BioAesthetics is headquartered in Research Triangle Park, North Carolina.

Allozymes is a deep technology company that specializes in ultrahigh-throughput microfluidics technology to enhance enzyme evolution and development. It focuses on creating sensitive and accurate assays for enzymatic reactions, alongside proprietary microfluidic chips and proteomics technologies. By employing molecular biology and process engineering, Allozymes aims to produce pure enzymes tailored for specific applications. This innovative platform enables clients to expedite custom enzyme development and to create novel, sustainable natural products.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

Gozen Bioworks offers solutions and biomaterials developed with a biomimicry approach by combining science, art, philosophy, and design to raise awareness and provide help to the planet, living creatures, and humanity. They develop and invent high-performance microbe-derived materials from natural inputs, such as next-generation leather, biotextiles, bioplastics, packaging, and interior materials.

Seppure Technologies is focused on transforming the energy-intensive processes of chemical separation and purification across various industries. By introducing innovative chemical-resistant nanofiltration membranes, Seppure aims to replace traditional methods like distillation and evaporation, which are known for their high energy consumption and environmental impact. The company's sustainable technology operates without the need for heat, significantly reducing global energy use, emissions, and pollution. This approach not only enhances efficiency in industrial-scale chemical separations but also contributes to a more sustainable future.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

Gozen Bioworks offers solutions and biomaterials developed with a biomimicry approach by combining science, art, philosophy, and design to raise awareness and provide help to the planet, living creatures, and humanity. They develop and invent high-performance microbe-derived materials from natural inputs, such as next-generation leather, biotextiles, bioplastics, packaging, and interior materials.

Vader Nanotechnologies creates a high-throughput screening method for identifying strains that can consume specific contaminants. Vader Nanotechnologies uses automation, image processing and computer vision, and analytical chemistry to find organisms that can grow solely on PFAS and other difficult-to-break-down chemicals. Vader optimizes and improves the performance of these organisms using directed evolution techniques.

SunGreenH2 is a company focused on producing green hydrogen through advanced nanotechnology and proprietary electrolysis systems. Founded in 2020 and headquartered in Singapore, with additional offices in Melbourne and London, the company has developed a modular and scalable electrolyser stack that enables efficient on-site hydrogen production using only sunlight and water. This innovative approach results in zero emissions and significantly reduces costs, facilitating the widespread adoption of green hydrogen across various sectors, including transportation, energy storage, and specialty chemicals. With over a decade of research in electrochemistry and nanotechnology, SunGreenH2 aims to unlock sustainable and scalable hydrogen solutions for industries worldwide.

Seppure Technologies is focused on transforming the energy-intensive processes of chemical separation and purification across various industries. By introducing innovative chemical-resistant nanofiltration membranes, Seppure aims to replace traditional methods like distillation and evaporation, which are known for their high energy consumption and environmental impact. The company's sustainable technology operates without the need for heat, significantly reducing global energy use, emissions, and pollution. This approach not only enhances efficiency in industrial-scale chemical separations but also contributes to a more sustainable future.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

Catalog is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

SunGreenH2 is a company focused on producing green hydrogen through advanced nanotechnology and proprietary electrolysis systems. Founded in 2020 and headquartered in Singapore, with additional offices in Melbourne and London, the company has developed a modular and scalable electrolyser stack that enables efficient on-site hydrogen production using only sunlight and water. This innovative approach results in zero emissions and significantly reduces costs, facilitating the widespread adoption of green hydrogen across various sectors, including transportation, energy storage, and specialty chemicals. With over a decade of research in electrochemistry and nanotechnology, SunGreenH2 aims to unlock sustainable and scalable hydrogen solutions for industries worldwide.

Allozymes is a deep technology company that specializes in ultrahigh-throughput microfluidics technology to enhance enzyme evolution and development. It focuses on creating sensitive and accurate assays for enzymatic reactions, alongside proprietary microfluidic chips and proteomics technologies. By employing molecular biology and process engineering, Allozymes aims to produce pure enzymes tailored for specific applications. This innovative platform enables clients to expedite custom enzyme development and to create novel, sustainable natural products.

Chinova Bioworks uses a natural and effective antimicrobial chitosan polymer with broad spectrum protection.

Kraken Sense specializes in an automated pathogen detection platform that utilizes advanced nanotechnology and real-time qPCR technology to identify bacterial contamination. The company's innovative solution allows for autonomous sampling from various sources, including liquids, solids, and aerosols. Its user-friendly IoT-enabled dashboard and analytics tools facilitate low-cost monitoring, making pathogen detection accessible and efficient. By employing state-of-the-art calibration techniques and cloud-based encryption, Kraken Sense enables clients to monitor and respond to contamination in real-time, ensuring a safer environment across multiple applications.

BioFeyn focuses on enhancing aquaculture by optimizing the feed for farmed fish. The company employs a specialized method of biodegradable nanoencapsulation that surrounds trace amounts of marine ingredients with naturally-derived compounds. This innovative approach improves digestion, absorption, and bioavailability of nutrients, ensuring that fish receive what they naturally consume in the ocean. By delivering essential nutrients and natural disease preventatives through a targeted delivery mechanism, BioFeyn aims to improve fish health and reduce environmental pollution. This method not only contributes to the sustainability of fish farming but also helps produce more nutritious fish for consumers.

BioFeyn focuses on enhancing aquaculture by optimizing the feed for farmed fish. The company employs a specialized method of biodegradable nanoencapsulation that surrounds trace amounts of marine ingredients with naturally-derived compounds. This innovative approach improves digestion, absorption, and bioavailability of nutrients, ensuring that fish receive what they naturally consume in the ocean. By delivering essential nutrients and natural disease preventatives through a targeted delivery mechanism, BioFeyn aims to improve fish health and reduce environmental pollution. This method not only contributes to the sustainability of fish farming but also helps produce more nutritious fish for consumers.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at providing clean air for individuals in polluted megacities such as Beijing and London. The company utilizes patented air purifying technology, which has been independently validated to be significantly more effective than traditional masks, filtering out dust and smoke particles through an active nanofiltration system. This innovative approach allows users to commute and exercise without the risks associated with pollution, promoting respiratory health while ensuring comfort and style. Aō Air's mission focuses on empowering urban residents to reclaim their environment and breathe clean air amidst increasing urban pollution challenges.

Catalog is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at providing clean air for individuals in polluted megacities such as Beijing and London. The company utilizes patented air purifying technology, which has been independently validated to be significantly more effective than traditional masks, filtering out dust and smoke particles through an active nanofiltration system. This innovative approach allows users to commute and exercise without the risks associated with pollution, promoting respiratory health while ensuring comfort and style. Aō Air's mission focuses on empowering urban residents to reclaim their environment and breathe clean air amidst increasing urban pollution challenges.

Allozymes is a deep technology company that specializes in ultrahigh-throughput microfluidics technology to enhance enzyme evolution and development. It focuses on creating sensitive and accurate assays for enzymatic reactions, alongside proprietary microfluidic chips and proteomics technologies. By employing molecular biology and process engineering, Allozymes aims to produce pure enzymes tailored for specific applications. This innovative platform enables clients to expedite custom enzyme development and to create novel, sustainable natural products.

MicroSynbiotiX Limited is a biotechnology company based in Cork City, Ireland, that specializes in developing oral vaccines tailored for the aquaculture sector. Founded in 2016, the company focuses on addressing the challenges posed by excessive antibiotic use in farmed fish. Through advancements in algal genomics and molecular biology, MicroSynbiotiX engineers microalgae to produce cost-effective therapeutic proteins and vaccines. This innovative approach utilizes microalgae as an oral delivery system, significantly reducing production costs and labor associated with traditional vaccine methods. The technology aims to decrease fish mortality rates, prevent bacterial and viral diseases that threaten fish stocks, and enhance global food security by providing affordable and user-friendly solutions for aquaculture.

Seppure Technologies is focused on transforming the energy-intensive processes of chemical separation and purification across various industries. By introducing innovative chemical-resistant nanofiltration membranes, Seppure aims to replace traditional methods like distillation and evaporation, which are known for their high energy consumption and environmental impact. The company's sustainable technology operates without the need for heat, significantly reducing global energy use, emissions, and pollution. This approach not only enhances efficiency in industrial-scale chemical separations but also contributes to a more sustainable future.

BioAesthetics LLC, founded in 2015 as a spin-out from Tulane University, is focused on developing innovative reconstruction options for breast cancer patients following mastectomies. The company specializes in a tissue-engineered nipple-areolar complex (NAC) that serves as an acellular graft to be used by plastic and reconstructive surgeons during the breast reconstruction phase. This product allows the patient's own cells to integrate with the graft, facilitating the regeneration of a natural nipple and areola. Currently in the pre-clinical phase, this patent-pending technology aims to provide a more effective and aesthetically pleasing solution for patients who have experienced incomplete or removed NACs due to illness, surgery, or congenital conditions. BioAesthetics is headquartered in Research Triangle Park, North Carolina.

Dahlia Biosciences is a biotechnology company based in California, founded in 2011. It focuses on DNA analysis and diagnostics, specializing in single-cell RNA analysis tools that are applicable for both research and diagnostic purposes. The company develops RNA detection tools utilizing CRISPR-Cas9 technology, which allows for the detection of multiple DNA and RNA biomarkers directly within cells and tissues. This innovative approach enables scientists to study and isolate cells with high precision and resolution, facilitating advancements in precision medicine research.

Seppure Technologies is focused on transforming the energy-intensive processes of chemical separation and purification across various industries. By introducing innovative chemical-resistant nanofiltration membranes, Seppure aims to replace traditional methods like distillation and evaporation, which are known for their high energy consumption and environmental impact. The company's sustainable technology operates without the need for heat, significantly reducing global energy use, emissions, and pollution. This approach not only enhances efficiency in industrial-scale chemical separations but also contributes to a more sustainable future.

MicroSynbiotiX Limited is a biotechnology company based in Cork City, Ireland, that specializes in developing oral vaccines tailored for the aquaculture sector. Founded in 2016, the company focuses on addressing the challenges posed by excessive antibiotic use in farmed fish. Through advancements in algal genomics and molecular biology, MicroSynbiotiX engineers microalgae to produce cost-effective therapeutic proteins and vaccines. This innovative approach utilizes microalgae as an oral delivery system, significantly reducing production costs and labor associated with traditional vaccine methods. The technology aims to decrease fish mortality rates, prevent bacterial and viral diseases that threaten fish stocks, and enhance global food security by providing affordable and user-friendly solutions for aquaculture.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

Dahlia Biosciences is a biotechnology company based in California, founded in 2011. It focuses on DNA analysis and diagnostics, specializing in single-cell RNA analysis tools that are applicable for both research and diagnostic purposes. The company develops RNA detection tools utilizing CRISPR-Cas9 technology, which allows for the detection of multiple DNA and RNA biomarkers directly within cells and tissues. This innovative approach enables scientists to study and isolate cells with high precision and resolution, facilitating advancements in precision medicine research.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

Dahlia Biosciences is a biotechnology company based in California, founded in 2011. It focuses on DNA analysis and diagnostics, specializing in single-cell RNA analysis tools that are applicable for both research and diagnostic purposes. The company develops RNA detection tools utilizing CRISPR-Cas9 technology, which allows for the detection of multiple DNA and RNA biomarkers directly within cells and tissues. This innovative approach enables scientists to study and isolate cells with high precision and resolution, facilitating advancements in precision medicine research.

BioAesthetics LLC, founded in 2015 as a spin-out from Tulane University, is focused on developing innovative reconstruction options for breast cancer patients following mastectomies. The company specializes in a tissue-engineered nipple-areolar complex (NAC) that serves as an acellular graft to be used by plastic and reconstructive surgeons during the breast reconstruction phase. This product allows the patient's own cells to integrate with the graft, facilitating the regeneration of a natural nipple and areola. Currently in the pre-clinical phase, this patent-pending technology aims to provide a more effective and aesthetically pleasing solution for patients who have experienced incomplete or removed NACs due to illness, surgery, or congenital conditions. BioAesthetics is headquartered in Research Triangle Park, North Carolina.

MicroSynbiotiX Limited is a biotechnology company based in Cork City, Ireland, that specializes in developing oral vaccines tailored for the aquaculture sector. Founded in 2016, the company focuses on addressing the challenges posed by excessive antibiotic use in farmed fish. Through advancements in algal genomics and molecular biology, MicroSynbiotiX engineers microalgae to produce cost-effective therapeutic proteins and vaccines. This innovative approach utilizes microalgae as an oral delivery system, significantly reducing production costs and labor associated with traditional vaccine methods. The technology aims to decrease fish mortality rates, prevent bacterial and viral diseases that threaten fish stocks, and enhance global food security by providing affordable and user-friendly solutions for aquaculture.

Catalog is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

BioAesthetics LLC, founded in 2015 as a spin-out from Tulane University, is focused on developing innovative reconstruction options for breast cancer patients following mastectomies. The company specializes in a tissue-engineered nipple-areolar complex (NAC) that serves as an acellular graft to be used by plastic and reconstructive surgeons during the breast reconstruction phase. This product allows the patient's own cells to integrate with the graft, facilitating the regeneration of a natural nipple and areola. Currently in the pre-clinical phase, this patent-pending technology aims to provide a more effective and aesthetically pleasing solution for patients who have experienced incomplete or removed NACs due to illness, surgery, or congenital conditions. BioAesthetics is headquartered in Research Triangle Park, North Carolina.

Chinova Bioworks uses a natural and effective antimicrobial chitosan polymer with broad spectrum protection.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at providing clean air for individuals in polluted megacities such as Beijing and London. The company utilizes patented air purifying technology, which has been independently validated to be significantly more effective than traditional masks, filtering out dust and smoke particles through an active nanofiltration system. This innovative approach allows users to commute and exercise without the risks associated with pollution, promoting respiratory health while ensuring comfort and style. Aō Air's mission focuses on empowering urban residents to reclaim their environment and breathe clean air amidst increasing urban pollution challenges.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

MicroSynbiotiX Limited is a biotechnology company based in Cork City, Ireland, that specializes in developing oral vaccines tailored for the aquaculture sector. Founded in 2016, the company focuses on addressing the challenges posed by excessive antibiotic use in farmed fish. Through advancements in algal genomics and molecular biology, MicroSynbiotiX engineers microalgae to produce cost-effective therapeutic proteins and vaccines. This innovative approach utilizes microalgae as an oral delivery system, significantly reducing production costs and labor associated with traditional vaccine methods. The technology aims to decrease fish mortality rates, prevent bacterial and viral diseases that threaten fish stocks, and enhance global food security by providing affordable and user-friendly solutions for aquaculture.

Chinova Bioworks uses a natural and effective antimicrobial chitosan polymer with broad spectrum protection.

ViaeX creates biological nanofiltration systems for water and air which are 400% more efficient than current solutions and enable selective pollutant and bacteria targeting. These systems are biodegradable, low cost, and rapidly scalable to enable fast deployment in cities around the world facing serious pollution issues. Advances in nanotechnology have paved the way for innovations that can combat the 9 million annual deaths caused by water and air pollution and reduce the $1.4 trillion global economic loss due to pollution annually. At ViaeX Technologies, they are focused on developing nanofiltration solutions to provide industrial and municipal customers with energy efficient, environmentally friendly, and selective filtration systems. Their technological platform has been developed over many years of fundamental research at UC Berkeley and UC San Diego. Based on novel physical-chemistry breakthroughs they have designed a system that overcomes many disadvantages of traditional filters by utilizing the potential of nanotechnology.

Catalog is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Vali Nanomedical Corporation is a biotechnology company established in 2013 and based in Los Angeles, California. The company specializes in developing a multidrug-delivery platform that leverages proprietary nanoparticles with a unique multilayered structure. This innovative technology enables a single nanoparticle to transport multiple drugs to tumors simultaneously, facilitating advanced cancer combination therapies that were previously unattainable. Vali's drug delivery systems are designed to enhance the specificity, efficacy, and safety of cancer treatments, providing healthcare providers with improved tools for targeted therapy.

ViaeX creates biological nanofiltration systems for water and air which are 400% more efficient than current solutions and enable selective pollutant and bacteria targeting. These systems are biodegradable, low cost, and rapidly scalable to enable fast deployment in cities around the world facing serious pollution issues. Advances in nanotechnology have paved the way for innovations that can combat the 9 million annual deaths caused by water and air pollution and reduce the $1.4 trillion global economic loss due to pollution annually. At ViaeX Technologies, they are focused on developing nanofiltration solutions to provide industrial and municipal customers with energy efficient, environmentally friendly, and selective filtration systems. Their technological platform has been developed over many years of fundamental research at UC Berkeley and UC San Diego. Based on novel physical-chemistry breakthroughs they have designed a system that overcomes many disadvantages of traditional filters by utilizing the potential of nanotechnology.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

MicroSynbiotiX Limited is a biotechnology company based in Cork City, Ireland, that specializes in developing oral vaccines tailored for the aquaculture sector. Founded in 2016, the company focuses on addressing the challenges posed by excessive antibiotic use in farmed fish. Through advancements in algal genomics and molecular biology, MicroSynbiotiX engineers microalgae to produce cost-effective therapeutic proteins and vaccines. This innovative approach utilizes microalgae as an oral delivery system, significantly reducing production costs and labor associated with traditional vaccine methods. The technology aims to decrease fish mortality rates, prevent bacterial and viral diseases that threaten fish stocks, and enhance global food security by providing affordable and user-friendly solutions for aquaculture.

Chinova Bioworks uses a natural and effective antimicrobial chitosan polymer with broad spectrum protection.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

Vali Nanomedical Corporation is a biotechnology company established in 2013 and based in Los Angeles, California. The company specializes in developing a multidrug-delivery platform that leverages proprietary nanoparticles with a unique multilayered structure. This innovative technology enables a single nanoparticle to transport multiple drugs to tumors simultaneously, facilitating advanced cancer combination therapies that were previously unattainable. Vali's drug delivery systems are designed to enhance the specificity, efficacy, and safety of cancer treatments, providing healthcare providers with improved tools for targeted therapy.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

Verdex Technologies Inc. is a company based in North Chesterfield, Virginia, that specializes in the design, patenting, and licensing of non-toxic nanofiber producing equipment for various applications, particularly in filtration and biomedical fields. The company leverages proprietary technology to mass produce advanced nanofibers, enabling the creation of high-quality nonwoven materials suitable for a wide range of uses, including engine filters, liquid filters, industrial air filters, and medical packaging. Verdex's innovative approach allows for the functionalization of nanofibers by incorporating nano-sized ingredients, enhancing the effectiveness of products like water filters. Committed to sustainability, Verdex utilizes biodegradable and bioresorbable polymers in its processes, ensuring that its production methods are environmentally friendly. Founded in 2011, the company aims to unlock the potential of nanofibers and improve quality of life through its advanced materials.

SouthWest NanoTechnologies, founded in 2001, specializes in the production of single-wall, few-wall, and multi-wall carbon nanotubes (CNTs) using its proprietary CoMoCAT® technology, developed by Professor Daniel Resasco. This innovative catalytic process operates in fluidized bed reactors, allowing for precise control over the diameter, chirality, and purity of the CNTs. The company has established itself as a leading supplier of high-purity carbon nanotubes, catering to over 1,000 materials developers across various industries, including consumer electronics, energy storage, and composite manufacturing. The unique structural properties of these carbon nanotubes, which include high thermal and chemical stability, make them suitable for a wide range of applications in electronics, healthcare, and advanced materials.